Cancer prevention and early detection by screening are key components for cancer control which, in turn, lead to a decrease in cancer incidence and mortality in the population. This goes along with the development and implementation of quality assurance guidelines in order to assure highly accurate screening procedures.
Cancer prevention and early detection are key elements in the Agency's work to elucidate the natural history of cancer, to implement primary and secondary prevention strategies on common cancers, to develop international networks, to provide scientific evidence on the validity of screening and early diagnosis tools, and to contribute to cancer control in general.
The Section comprises three Groups, namely the Prevention Group, the Quality Assurance Group and the Screening Group. Research projects are implemented in the European Union and in low- and medium-resource countries, and are focusing on the early detection and prevention of cervix, breast, head and neck, colorectal and skin cancers.
The Section receives funding from, among others, the
Bill & Melinda Gates Foundation, USA, the
European Commission, and the
Agence française de sécurité sanitaire de l'environnement et du travail, France.
